Recommendations of severe acute respiratory syndrome coronavirus 2 vaccination in renal transplant recipients
10.3760/cma.j.cn421203-20210927-00241
- VernacularTitle:肾移植受者新型冠状病毒疫苗接种建议
- Author:
Jun LIN
1
;
Xiaoming DING
;
Yichen ZHU
;
Jian ZHANG
;
Yang YANG
;
Ye TIAN
;
Bingyi SHI
;
Wujun XUE
Author Information
1. 首都医科大学附属北京友谊医院泌尿外科，北京 100050
- Keywords:
Kidney transplantation;
Vaccine inoculation;
Severe acute respiratory syndrome coronavirus 2
- From:
Chinese Journal of Organ Transplantation
2022;43(2):67-73
- CountryChina
- Language:Chinese
-
Abstract:
As novel coronavirus infection has become a major public health problem affecting human health, vaccination is the most effective means of preventing novel coronavirus infection.Therefore, besides implementing regular epidemic prevention and control, it has become the consensus of international community for effective prevention and control of novel coronavirus infection through accelerating the speed of novel coronavirus vaccination, expanding the scope of vaccination and improving public vaccination rate.Kidney transplant recipients are at an elevated risk of novel coronavirus infection.This population has been in a low immune state for a long time.Thus there are problems such as reduced immunogenicity of COVID-19 vaccine, selection and use of vaccine and breakthrough of infection.Based upon the published international and domestic data, this paper serves as a practical reference for clinicians and healthcare workers to provide consultations to kidney transplant recipients about the administration of novel coronavirus vaccine.
